Axalta Posts Record Q2 Adjusted EBITDA of $305M, Guides FY Adjusted EPS $2.55-$2.70 Ahead of Merger Vote
AXTA sits 40% above its 52-week low of $24.937.
Summary
Axalta reported record Q2 2026 Adjusted EBITDA of $305 million and Adjusted Diluted EPS of $0.72, both quarterly highs, and issued full-year guidance above consensus estimates. The strong results come one week before the shareholder vote on the AkzoNobel merger.
Key Events · Earnings and Guidance · AXTA
-
Record Q2 Profitability
Adjusted EBITDA reached a quarterly record of $305 million (22.7% margin), up 5% YoY, while Adjusted Diluted EPS hit a record $0.72, up 13% YoY, driven by strong conversion on higher sales and lower interest expense.
-
Full-Year Guidance Raised
Axalta guided FY2026 Adjusted EBITDA to $1.14-$1.17 billion and Adjusted Diluted EPS to $2.55-$2.70, with free cash flow exceeding $500 million, reflecting confidence in sustained operational momentum.
-
Merger Vote on August 5
CEO Chris Villavarayan highlighted the upcoming Special General Meeting to approve the merger of equals with AkzoNobel, calling it a 'compelling' combination that creates a premier global coatings company with significant value creation opportunities.
-
Balance Sheet Strength
Total net leverage fell to a historic low of 2.2x, supported by $152 million in operating cash flow and $107 million in free cash flow during the quarter, providing ample capacity for the pending merger.
Analysis · AXTA · Industrial Applications And Services
Axalta delivered a strong second quarter with record profitability metrics — Adjusted EBITDA hit $305 million and Adjusted Diluted EPS reached $0.72, both quarterly records. The company also issued full-year guidance calling for Adjusted EBITDA of $1.14-$1.17 billion and Adjusted Diluted EPS of $2.55-$2.70, signaling confidence in sustained momentum. These results land just one week before the August 5 shareholder vote on the proposed merger of equals with AkzoNobel, a deal that would create a premier global coatings company. The earnings beat and raised outlook strengthen management's hand heading into that pivotal vote, while the record-low net leverage of 2.2x underscores a healthy balance sheet capable of supporting the combined entity.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 30% of the 1759 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXTA was trading at $34.93 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $24.94 to $35.72. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.